230 related articles for article (PubMed ID: 31230882)
1. Immunization with a peptide mimicking Lipoteichoic acid protects mice against Staphylococcus aureus infection.
Yi XY; Huang ZX; Hou XR; Zhu P; Wang XY; Luo HB; Liu BY
Vaccine; 2019 Jul; 37(31):4325-4335. PubMed ID: 31230882
[TBL] [Abstract][Full Text] [Related]
2. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
[TBL] [Abstract][Full Text] [Related]
3. Novel peptides screened by phage display peptide library can mimic epitopes of the FnBPA-A protein and induce protective immunity against Staphylococcus aureus in mice.
Li JN; Wang H; Han YX; Zhao YT; Zhou HH; Xu J; Li L
Microbiologyopen; 2019 Oct; 8(10):e910. PubMed ID: 31452334
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a peptide mimicking lipoteichoic acid induces memory B cells in BALB/c mice.
Yi XY; Hou XR; Huang ZX; Zhu P; Liu BY
BMC Infect Dis; 2024 Apr; 24(1):371. PubMed ID: 38566017
[TBL] [Abstract][Full Text] [Related]
5. Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus.
Chen Y; Liu B; Yang D; Li X; Wen L; Zhu P; Fu N
J Med Microbiol; 2011 Jul; 60(Pt 7):995-1002. PubMed ID: 21436375
[TBL] [Abstract][Full Text] [Related]
6. Clearance of Staphylococcus aureus from
Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
[No Abstract] [Full Text] [Related]
7. Identification of a novel linear B-cell epitope as a vaccine candidate in the N2N3 subdomain of Staphylococcus aureus fibronectin-binding protein A.
Ma J; Wei Y; Zhang L; Wang X; Yao D; Liu D; Liu W; Yu S; Yu Y; Wu Z; Yu L; Zhu Z; Cui Y
J Med Microbiol; 2018 Mar; 67(3):423-431. PubMed ID: 29458526
[TBL] [Abstract][Full Text] [Related]
8. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
10. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
[TBL] [Abstract][Full Text] [Related]
11. Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice.
Leemans JC; Heikens M; van Kessel KP; Florquin S; van der Poll T
Clin Diagn Lab Immunol; 2003 Sep; 10(5):950-3. PubMed ID: 12965932
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections.
Wergeland H; Endresen C; Natås OB; Aasjord P; Oeding P
Acta Pathol Microbiol Immunol Scand B; 1984 Oct; 92(5):265-9. PubMed ID: 6516850
[TBL] [Abstract][Full Text] [Related]
13. A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus.
Wang XY; Huang ZX; Chen YG; Lu X; Zhu P; Wen K; Fu N; Liu BY
PLoS One; 2015; 10(8):e0136888. PubMed ID: 26317210
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
[TBL] [Abstract][Full Text] [Related]
15. Corneal antibody levels to ribitol teichoic acid in rabbits immunized with staphylococcal antigens using various routes.
Mondino BJ; Brawman-Mintzer O; Adamu SA
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1553-8. PubMed ID: 3623839
[TBL] [Abstract][Full Text] [Related]
16. Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.
Beining PR; Flannery GM; Prescott B; Baker PJ
Infect Immun; 1980 Jul; 29(1):132-9. PubMed ID: 6967453
[TBL] [Abstract][Full Text] [Related]
17. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.
McKenney D; Pouliot KL; Wang Y; Murthy V; Ulrich M; Döring G; Lee JC; Goldmann DA; Pier GB
Science; 1999 May; 284(5419):1523-7. PubMed ID: 10348739
[TBL] [Abstract][Full Text] [Related]
18. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
[TBL] [Abstract][Full Text] [Related]
19. Active immunization with an octa-valent Staphylococcus aureus antigen mixture in models of S. aureus bacteremia and skin infection in mice.
van den Berg S; Koedijk DG; Back JW; Neef J; Dreisbach A; van Dijl JM; Bakker-Woudenberg IA; Buist G
PLoS One; 2015; 10(2):e0116847. PubMed ID: 25710376
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
Chan JYH; Clow F; Pearson V; Langley RJ; Fraser JD; Radcliff FJ
Immunol Cell Biol; 2024; 102(5):365-380. PubMed ID: 38572664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
